Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

<p>Background: The burden of vascular diseases remains substantial in patients with type 2 diabetes, requiring identification of further risk markers. We tested the absence of dorsalis pedis and posterior tibial pulses as predictors of major macrovascular and microvascular events, death, and c...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Mohammedi, K, Woodward, M, Zoungas, S, Q, L, Harrap, Stephen, S, Patel, A, Marre, M, Chalmers, J
Μορφή:	Journal article
Έκδοση:	American Diabetes Association 2016

Παρόμοια τεκμήρια

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
ανά: Mohammedi, K, κ.ά.
Έκδοση: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
ανά: Mohammedi, K, κ.ά.
Έκδοση: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
ανά: Blomster, J, κ.ά.
Έκδοση: (2017)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
ανά: Kamel Mohammedi, κ.ά.
Έκδοση: (2021-01-01)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
ανά: Jun, M, κ.ά.
Έκδοση: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
ανά: Jun, M, κ.ά.
Έκδοση: (2017)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
ανά: Zoungas, S, κ.ά.
Έκδοση: (2012)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
ανά: Clarke, P, κ.ά.
Έκδοση: (2010)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2018)

Severe Hypoglycemia and Risks of Vascular Events and Death
ανά: Zoungas, S, κ.ά.
Έκδοση: (2010)

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
ανά: Hamet, P, κ.ά.
Έκδοση: (2017)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
ανά: Philip M Clarke, κ.ά.
Έκδοση: (2010-02-01)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ανά: Patel, A, κ.ά.
Έκδοση: (2008)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2019)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
ανά: Perkovic, V, κ.ά.
Έκδοση: (2013)

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study
ανά: Thomas, M, κ.ά.
Έκδοση: (2018)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
ανά: Zoungas, S, κ.ά.
Έκδοση: (2009)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
ανά: Mohammedi, K, κ.ά.
Έκδοση: (2018)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
ανά: Rahman, F, κ.ά.
Έκδοση: (2019)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2017)

Microvascular outcomes in type 2 diabetes - Authors' reply
ανά: Zoungas, S, κ.ά.
Έκδοση: (2017)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
ανά: van Steen, S, κ.ά.
Έκδοση: (2018)

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.
ανά: Morton, J, κ.ά.
Έκδοση: (2012)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
ανά: Rådholm, K, κ.ά.
Έκδοση: (2018)

Outcomes of Vascular Intervention in Diabetic Patients with Peripheral Arterial Disease
ανά: Mahfujul Z. Haque, κ.ά.
Έκδοση: (2022-12-01)

Assessment of peripheral vascular function with photoplethysmographic pulse amplitude
ανά: Tatiana Kuznetsova, κ.ά.
Έκδοση: (2011-04-01)

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
ανά: Selvin, E, κ.ά.
Έκδοση: (2019)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
ανά: Merlin C. Thomas, κ.ά.
Έκδοση: (2018-07-01)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
ανά: Zoungas, S, κ.ά.
Έκδοση: (2017)

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes
ανά: Zhang, Z, κ.ά.
Έκδοση: (2019)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
ανά: Patel, A, κ.ά.
Έκδοση: (2007)

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review
ανά: Kamel Mohammedi, κ.ά.
Έκδοση: (2024-12-01)

Decision‐making for early major amputation in selected diabetic foot ulcer patients with peripheral vascular disease
ανά: Lim York Tee Gorden, κ.ά.
Έκδοση: (2022-10-01)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
ανά: Hata, J, κ.ά.
Έκδοση: (2012)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
ανά: Welsh, P, κ.ά.
Έκδοση: (2018)

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
ανά: Heart Protection Study Collaborative Group
Έκδοση: (2007)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
ανά: Kamel Mohammedi, κ.ά.
Έκδοση: (2022-12-01)

Lowering blood pressure reduces renal events in type 2 diabetes.
ανά: de Galan, B, κ.ά.
Έκδοση: (2009)